- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $173.41M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $131.71M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $0 |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $330M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $757.26M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $449.67M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $319.81M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $299.39M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $362.58M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $344.86M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.04B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.05B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.17B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.19B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 973.15M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $974K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$90.11M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $762.17M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $796.12M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.05 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.05 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $69.19M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $54.65M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$53.47M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$70.31M |
| Revenue | Q1 2025 · Mar 31, 2024 | $87.15M |